Site-specific PEGylation of lidamycin and its antitumor activity
In this study, N-terminal site-specific mono-PEGylation of the recombinant lidamycin apoprotein (rLDP) of lidamycin (LDM) was prepared using a polyethyleneglycol (PEG) derivative (Mw 20 kDa) through a reactive terminal aldehyde group under weak acidic conditions (pH 5.5). The biochemical properties...
Main Authors: | Liang Li, Boyang Shang, Lei Hu, Rongguang Shao, Yongsu Zhen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-05-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383515000490 |
Similar Items
-
PEGylated versus Non-PEGylated pH-Sensitive Liposomes: New Insights from a Comparative Antitumor Activity Study
by: Shirleide Santos Nunes, et al.
Published: (2022-01-01) -
Site-Specific PEGylation of Therapeutic Proteins
by: Jonathan K. Dozier, et al.
Published: (2015-10-01) -
The Research of Toxicity and Sensitization Potential of PEGylated Silver and Gold Nanomaterials
by: Dong-Han Lee, et al.
Published: (2021-12-01) -
PEGylation of human interferon-α2b with modified amino acids increases circulation half-life and antiproliferative activity
by: Syeda Kiran Shahzadi, et al.
Published: (2023-12-01) -
Fabrication of Transparent PEGylated Antifouling Coatings via One-Step Pyrogallol Deposition
by: Shang-Lin Yeh, et al.
Published: (2023-06-01)